InGeneron, Inc.
PrivateLast Round
Series D
Extension
Jun 11, 2019
Total Funding Raised
$47.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InGeneron, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series D Extension round in June 2019.
InGeneron, Inc. is a biotechnology company that develops regenerative cell therapy platforms for point-of-care orthopedic treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InGeneron, Inc. Comparables
Compare InGeneron, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GID BIO, Inc. | 91% | |
| Lipogems International | 91% | |
| Celling Biosciences | 86% |
For institutional investors. Book with your work email.
InGeneron, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jun 11, 2019 | ||||
| Series D | Mar 6, 2017 | ||||
| VC Round | Dec 20, 2016 | ||||
| Accelerator | Dec 5, 2016 | ||||
| Series C | Jul 7, 2016 | ||||
Grant | Aug 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InGeneron, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| German Accelerator | Accelerator |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 443% MoM, from 366 to 2K.
- Nov 6, 2025
Monthly visitors grew 36% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
InGeneron, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InGeneron, Inc.'s valuation, stock price, and market status.
Is InGeneron, Inc. a public or private company?
InGeneron, Inc. is a private company.
What is the current stock price of InGeneron, Inc.?
InGeneron, Inc. is a private company, so its shares have no public market price. Caplight tracks InGeneron, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InGeneron, Inc. worth (valuation)?
Valuation information for InGeneron, Inc. is not publicly available.
Can I buy InGeneron, Inc. stock?
InGeneron, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InGeneron, Inc.'s last funding round?
InGeneron, Inc.'s most recent funding round was Series D Extension on June 11, 2019.
Who are the main investors in InGeneron, Inc.?
Key investors in InGeneron, Inc. include German Accelerator, Cancer Prevention and Research Institute of Texas.
Will InGeneron, Inc. IPO soon?
No public IPO plans have been announced for InGeneron, Inc..
How can I track InGeneron, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in InGeneron, Inc.'s shares on secondary markets.